相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of albumin and compounded plasma for plasma exchange in acquired thrombotic thrombocytopenic purpura
Ruiqin Hou et al.
JOURNAL OF CLINICAL APHERESIS (2020)
A regimen with caplacizumab, immunosuppression, and plasma exchange prevents unfavorable outcomes in immune-mediated TTP
Paul Coppo et al.
BLOOD (2020)
Center Effects in Hospital Mortality of Critically Ill Patients With Hematologic Malignancies*
Lucie Biard et al.
CRITICAL CARE MEDICINE (2019)
Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura
Elie Azoulay et al.
INTENSIVE CARE MEDICINE (2019)
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
M. Scully et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Starting Young: Trends in Opioid Therapy Among US Adolescents and Young Adults With Inflammatory Bowel Disease in the Truven MarketScan Database Between 2007 and 2015
Anava A. Wren et al.
INFLAMMATORY BOWEL DISEASES (2018)
Association of Facility Type With Procedural-Related Morbidities and Adverse Events Among Patients Undergoing Induced Abortions
Sarah C. M. Roberts et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura
Matthieu Jestin et al.
BLOOD (2018)
Clinical and laboratory diagnosis of TTP: an integrated approach
Thita Chiasakul et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2018)
Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism
Craig I. Coleman et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015
Evaren E. Page et al.
BLOOD ADVANCES (2017)
Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study
Ygal Benhamou et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Von Willebrand Factor - A New Target for TTP Treatment?
Agnes Veyradier
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
Mazin T. Abdelghany et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy
Eric Mariotte et al.
LANCET HAEMATOLOGY (2016)
Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality
Ruchika Goel et al.
BLOOD (2015)
Understanding organ dysfunction in thrombotic thrombocytopenic purpura
Pier Mannuccio Mannucci
INTENSIVE CARE MEDICINE (2015)
Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity
L. Zafrani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange
Paul Coppo et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2015)
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura
Miguel Hie et al.
BLOOD (2014)
How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Safety and Efficacy of Cryoprecipitate-Poor Plasma as a Replacement Fluid for Therapeutic Plasma Exchange in Thrombotic Thrombocytopenic Purpura: A Single Center Retrospective Evaluation
Bianca Stefanello et al.
JOURNAL OF CLINICAL APHERESIS (2014)
Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: A retrospective multicenter study
Serdal Korkmaz et al.
TRANSFUSION AND APHERESIS SCIENCE (2013)
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center
Antoine Froissart et al.
CRITICAL CARE MEDICINE (2012)
Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience
Ygal Benhamou et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Causes and risk factors of death in patients with thrombotic microangiopathies
Vincent Peigne et al.
INTENSIVE CARE MEDICINE (2012)
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
Marie Scully et al.
BLOOD (2011)
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study
Carlo L. Balduini et al.
ANNALS OF HEMATOLOGY (2010)
Survival and relapse in patients with thrombotic thrombocytopenic purpura
Johanna A. Kremer Hovinga et al.
BLOOD (2010)
Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: A retrospective multicenter study
Fevzi Altuntas et al.
TRANSFUSION AND APHERESIS SCIENCE (2007)
An evaluation of ciclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura
Spero R. Cataland et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange
Michael Darmon et al.
CRITICAL CARE MEDICINE (2006)
Efficiency of curative and prophylactic treatment with rituximab in ADAMTS 13-deficient thrombotic thrombocytopenic purpura:: a study of 11 cases
F Fakhouri et al.
BLOOD (2005)
Outcome of severe adult thrombotic microangiopathies in the intensive care unit
F Pene et al.
INTENSIVE CARE MEDICINE (2005)
Current epidemiology of septic shock - The CUB-Rea network
D Annane et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome
P Coppo et al.
MEDICINE (2003)
Thrombotic thrombocytopenic purpura (TTP): Initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases
CW Yang et al.
RENAL FAILURE (2003)
ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions
JF Dong et al.
BLOOD (2002)
Mechanisms of disease - Thrombotic microangiopathies
JL Moake
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Vincristine as treatment for recurrent episodes of thrombotic thrombocytopenic purpura
F Ferrara et al.
ANNALS OF HEMATOLOGY (2002)
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
GG Levy et al.
NATURE (2001)
Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases
A Veyradier et al.
BLOOD (2001)
分享论文
